|
|
Post by tarheelblue004 on Sept 22, 2023 7:10:56 GMT -5
Or - and this is a crazy thought - MS inviting companies to the conference and MS initiating price coverage have nothing to do with each other.
|
|
|
|
Post by prcgorman2 on Sept 22, 2023 7:17:26 GMT -5
Speaking of being objective I’m perplexed why some are obsessed with this idea that the Morgan Stanley investor conference was all about MS taking a hard look at MNKD and initiating coverage. As agedhippie points out, hundreds of potential investments and investors at the conference. Why should we assume a lack of coverage by MS would be a failure? Does MS cover all of the potential investments that come to their conferences? Is there some other indications in the historical record that points to Morgan Stanley coverage if you’re invited to their conference? Is there some indication that coverage by Morgan Stanley automatically increases your share price and that your fortunes are assured? If we get MS coverage, outstanding, if we don’t, what is the downside? Is the SP going to crash? Is the work of MannKind to improve their outlook with studies and pipeline and manufacturing improvements at risk without MS coverage? Sorry if I interrupted the pity party. As you were. |
|
|
|
Post by sportsrancho on Sept 22, 2023 7:38:39 GMT -5
I’m not worried about it. I think it’s bullish that we at last got invited again, because they had completely quit even inviting us.
Maybe it all doesn’t make any difference but it’s memory recognition of when they put out a price target the stock seems to go there, down or up, and big hedge funds when you’re invested with them, give price targets for the stocks on your watchlist. My landlord watches his Stiffel recommendations like a hawk. Because he pays them to manage his money. #RetirementAccount.
|
|
|
|
Post by agedhippie on Sept 22, 2023 9:10:10 GMT -5
Speaking of being objective I’m perplexed why some are obsessed with this idea that the Morgan Stanley investor conference was all about MS taking a hard look at MNKD and initiating coverage. As agedhippie points out, hundreds of potential investments and investors at the conference. Why should we assume a lack of coverage by MS would be a failure? Does MS cover all of the potential investments that come to their conferences? Is there some other indications in the historical record that points to Morgan Stanley coverage if you’re invited to their conference? Is there some indication that coverage by Morgan Stanley automatically increases your share price and that your fortunes are assured? If we get MS coverage, outstanding, if we don’t, what is the downside? Is the SP going to crash? Is the work of MannKind to improve their outlook with studies and pipeline and manufacturing improvements at risk without MS coverage? Sorry if I interrupted the pity party. As you were. A lack of coverage by Morgan Stanley is not a failure. Likewise presenting at the conference is not an indication of Morgan Stanley's favor. You get to these conferences by asking if you can present and they then stack rank you to decide if they will accept your application. While being covered by Morgan Stanley may be a minor consideration it's not going to get you a place regardless of merit. Morgan Stanley coverage is a red herring at this point. No institutional investor is going to buy on an MS recommendation for a company the size of MNKD. The expectation is that for companies companies with this sort of market cap the best you are going to get is a green analyst and why would you rely on them? The reason recommendations impact the big companies is because the analysts for those companies are seen as more competent. Now, that's not to say that the quality of the analysis pans out like that, but it's what the market believes. There are things like giving an earnings forecast, and diversifying the revenue streams that would have far more tangible impact on the share price and analyst coverage than MS adding MNKD to some junior analyst's mountain of stocks that they cover. |
|
|
|
Post by prcgorman2 on Sept 22, 2023 10:33:58 GMT -5
Speaking of being objective I’m perplexed why some are obsessed with this idea that the Morgan Stanley investor conference was all about MS taking a hard look at MNKD and initiating coverage. As agedhippie points out, hundreds of potential investments and investors at the conference. Why should we assume a lack of coverage by MS would be a failure? Does MS cover all of the potential investments that come to their conferences? Is there some other indications in the historical record that points to Morgan Stanley coverage if you’re invited to their conference? Is there some indication that coverage by Morgan Stanley automatically increases your share price and that your fortunes are assured? If we get MS coverage, outstanding, if we don’t, what is the downside? Is the SP going to crash? Is the work of MannKind to improve their outlook with studies and pipeline and manufacturing improvements at risk without MS coverage? Sorry if I interrupted the pity party. As you were. A lack of coverage by Morgan Stanley is not a failure. Likewise presenting at the conference is not an indication of Morgan Stanley's favor. You get to these conferences by asking if you can present and they then stack rank you to decide if they will accept your application. While being covered by Morgan Stanley may be a minor consideration it's not going to get you a place regardless of merit. Morgan Stanley coverage is a red herring at this point. No institutional investor is going to buy on an MS recommendation for a company the size of MNKD. The expectation is that for companies companies with this sort of market cap the best you are going to get is a green analyst and why would you rely on them? The reason recommendations impact the big companies is because the analysts for those companies are seen as more competent. Now, that's not to say that the quality of the analysis pans out like that, but it's what the market believes. There are things like giving an earnings forecast, and diversifying the revenue streams that would have far more tangible impact on the share price and analyst coverage than MS adding MNKD to some junior analyst's mountain of stocks that they cover. Interesting points, especially about guidance and diversification. One of the interesting things about Mike's presentations this year is a repetition of the ways analysts (and those who post on investment social media) can estimate MannKind revenues based on patient counts for PAH and other indications, manufacturing revenue, and royalties for Tyvaso DPI, as well as sharing estimates on the "Insulin Business Unit" comprised of Afrezza and V-Go. I think that is essentially revenue guidance, is it not? And on the point of diversification, there has been very obvious effort to bring the MannKind clofazimine and nintedanib pipeline products forward for FDA approval. As much work as all that is, it must still seem like baby steps to large investors in companies like Merck, et cetera. Regardless, MTOI says buy shares while they're "cheap" and we've all heard "buy low, sell high". So MS coverage would be nice to have but I won't whine and lament "if only" if MS coverage doesn't immediately materialize. |
|
|
|
Post by sayhey24 on Sept 22, 2023 11:40:12 GMT -5
How much business do you have to do or promise to do with MS to get coverage and have them pump the stock? It seems Mike did not write a big enough check. The pps has been diving every since this conference. Maybe he would have done better to stay home.
|
|
|
|
Post by prcgorman2 on Sept 22, 2023 12:00:03 GMT -5
How much business do you have to do or promise to do with MS to get coverage and have them pump the stock? It seems Mike did not write a big enough check. The pps has been diving every since this conference. Maybe he would have done better to stay home. You're making the argument the MNKD share price is being driven by whether or not Mike presented at the Morgan Stanley conference and MS initiated coverage? That's what the share price has been hanging on? Is this a new phenomenon or has the share price always been manipulated this way? How could any of the majority shareholders (i.e., institutional shareholders) have decided to take a long position in MNKD without Morgan Stanley? It defies logic! Wow. Just wow. |
|
|
|
Post by mymann on Sept 22, 2023 12:03:03 GMT -5
MS invitation was supposed to be a big deal. When Mike talks, no one listens.
|
|
|
|
Post by uvula on Sept 22, 2023 12:20:14 GMT -5
MS invitation was supposed to be a big deal. When Mike talks, no one listens. In reality, it was never a big deal. We (proboards groupies) had nothing else to discuss so we made it a big deal. |
|
|
|
Post by castlerockchris on Sept 22, 2023 12:32:24 GMT -5
MS invitation was supposed to be a big deal. When Mike talks, no one listens. mymann, I have two questions, and I am being very genuine when I ask. Given the pessimism in your comments...If you are an investor in MNKD, why do you hold it? And if you aren't a share holder (which is fine by me), why do you come to the board? I just curious. |
|
|
|
Post by mymann on Sept 22, 2023 12:37:45 GMT -5
I am long time holder since 2008. The disappointing investment I made in mnkd have turned me into a sour puse. I hold for a buy out or buy in from UTHR. Get rid of the poor management team.
|
|
|
|
Post by prcgorman2 on Sept 22, 2023 14:13:01 GMT -5
I am long time holder since 2008. The disappointing investment I made in mnkd have turned me into a sour puse. I hold for a buy out or buy in from UTHR. Get rid of the poor management team. Oops, you already told us you sold all your shares earlier this year. I'll say it again. You're over-paid. |
|
|
|
Post by sportsrancho on Sept 22, 2023 14:31:20 GMT -5
I don’t remember him saying, that but I do remember how long he’s been invested.
|
|
|
|
Post by letitride on Sept 22, 2023 16:33:35 GMT -5
My thought is MS finest are BTFD for themselves and their in good company with me. Lets Ride!
|
|
|
|
Post by uvula on Sept 22, 2023 16:48:22 GMT -5
Not that it really matters but novafet started the "I'm out" thread. I don't think mymann ever said that.
|
|
